News West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Market Closed - Nyse Other stock markets 04:00:01 2024-05-03 pm EDT			5-day change	1st Jan Change
365 ^USD	-0.93%		+1.27%	+3.66%

Apr. 26	Declaration of Voting Results of the West Pharmaceutical Services Inc	CI
Apr. 26	Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

West to Participate in Upcoming Investor Conference	Apr. 30	PR
Declaration of Voting Results of the West Pharmaceutical Services Inc	Apr. 26	CI
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc	Apr. 26	CI
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating	Apr. 26	MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423	Apr. 26	MT
Health Care Drops Amid Mixed Earnings -- Health Care Roundup	Apr. 25	DJ
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.	Apr. 25	CI
West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised	Apr. 25	MT
Transcript : West Pharmaceutical Services, Inc., Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Stephens Adjusts West Pharmaceutical Services Price Target to $420 From $400	Apr. 25	MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M	Apr. 25	MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29	Apr. 25	MT
West Pharmaceutical: Q1 Earnings Snapshot	Apr. 25	AQ
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend	Apr. 25	PR
West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
West Pharmaceutical Services, Inc. Reaffirms Earnings Guidance for the Full Year 2024	Apr. 25	CI
West Pharmaceutical Services, Inc. Announces Third Quarter 2024 Dividend, Payable on August 7, 2024	Apr. 25	CI
Ex-dividend day	Apr. 22	FA
West to Host First-Quarter 2024 Conference Call	Apr. 11	PR
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	Mar. 29	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Summary

Filters